Daiwa Securities Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
191
| – | – | ﹤0.01% | 1288 |
|
|
2025
Q1 | $1K | Hold |
191
| – | – | ﹤0.01% | 1261 |
|
|
2024
Q4 | $1K | Hold |
191
| – | – | ﹤0.01% | 1272 |
|
|
2024
Q3 | $1K | Hold |
191
| – | – | ﹤0.01% | 1261 |
|
|
2024
Q2 | $1K | Hold |
191
| – | – | ﹤0.01% | 1294 |
|
|
2024
Q1 | $1K | Hold |
191
| – | – | ﹤0.01% | 1301 |
|
|
2023
Q4 | $1K | Hold |
191
| – | – | ﹤0.01% | 1300 |
|
|
2023
Q3 | $1K | Hold |
191
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q2 | $1K | Hold |
191
| – | – | ﹤0.01% | 1294 |
|
|
2023
Q1 | $1K | Hold |
191
| – | – | ﹤0.01% | 1276 |
|
|
2022
Q4 | $1K | Hold |
191
| – | – | ﹤0.01% | 1286 |
|
|
2022
Q3 | $2K | Hold |
191
| – | – | ﹤0.01% | 1243 |
|
|
2022
Q2 | $2K | Hold |
191
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q1 | $2K | Hold |
191
| – | – | ﹤0.01% | 1265 |
|
|
2021
Q4 | $3K | Hold |
191
| – | – | ﹤0.01% | 1252 |
|
|
2021
Q3 | $3K | Buy |
191
+71
| +59% | +$1.12K | ﹤0.01% | 1226 |
|
|
2021
Q2 | $3K | Hold |
120
| – | – | ﹤0.01% | 1117 |
|
|
2021
Q1 | $2K | Hold |
120
| – | – | ﹤0.01% | 1163 |
|
|
2020
Q4 | $2K | Sell |
120
-181
| -60% | -$3.02K | ﹤0.01% | 1139 |
|
|
2020
Q3 | $3K | Hold |
301
| – | – | ﹤0.01% | 1110 |
|
|
2020
Q2 | $3K | Hold |
301
| – | – | ﹤0.01% | 1127 |
|
|
2020
Q1 | $3K | Hold |
301
| – | – | ﹤0.01% | 1131 |
|
|
2019
Q4 | $5K | Sell |
301
-34
| -10% | -$565 | ﹤0.01% | 1097 |
|
|
2019
Q3 | $4K | Hold |
335
| – | – | ﹤0.01% | 1082 |
|
|
2019
Q2 | $5K | Hold |
335
| – | – | ﹤0.01% | 1088 |
|
|
2019
Q1 | $6K | Buy |
335
+87
| +35% | +$1.56K | ﹤0.01% | 1060 |
|
|
2018
Q4 | $6K | Hold |
248
| – | – | ﹤0.01% | 1033 |
|
|
2018
Q3 | $6K | Hold |
248
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q2 | $5K | Hold |
248
| – | – | ﹤0.01% | 1085 |
|
|
2018
Q1 | $4K | Buy |
+248
| New | +$4K | ﹤0.01% | 1082 |
|